Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386797584> ?p ?o ?g. }
- W4386797584 endingPage "108317" @default.
- W4386797584 startingPage "108317" @default.
- W4386797584 abstract "Gene therapy is a flourishing field with the potential to revolutionize the treatment of genetic diseases. The emergence of CRISPR-Cas9 has significantly advanced targeted and efficient genome editing. Although CRISPR-Cas9 has demonstrated promising potential applications in various genetic disorders, it faces limitations in simultaneously targeting multiple genes. Novel CRISPR systems, such as Cas12 and Cas13, have been developed to overcome these challenges, enabling multiplexing and providing unique advantages. Cas13, in particular, targets mRNA instead of genomic DNA, permitting precise gene expression control and mitigating off-target effects. This review investigates the potential of Cas12 and Cas13 in ocular gene therapy applications, such as suppression of inflammation and cell death. In addition, the capabilities of Cas12 and Cas13 are explored in addressing potential targets related with disease mechanisms such as aberrant isoforms, mitochondrial genes, cis-regulatory sequences, modifier genes, and long non-coding RNAs. Anatomical accessibility and relative immune privilege of the eye provide an ideal organ system for evaluating these novel techniques' efficacy and safety. By targeting multiple genes concurrently, CRISPR-Cas12 and Cas13 systems hold promise for treating a range of ocular disorders, including glaucoma, retinal dystrophies, and age-related macular degeneration. Nonetheless, additional refinement is required to ascertain the safety and efficacy of these approaches in ocular disease treatments. Thus, the development of Cas12 and Cas13 systems marks a significant advancement in gene therapy, offering the potential to devise effective treatments for ocular disorders." @default.
- W4386797584 created "2023-09-17" @default.
- W4386797584 creator A5001466650 @default.
- W4386797584 creator A5012657407 @default.
- W4386797584 creator A5022547046 @default.
- W4386797584 creator A5072761752 @default.
- W4386797584 creator A5092886545 @default.
- W4386797584 date "2023-12-01" @default.
- W4386797584 modified "2023-10-18" @default.
- W4386797584 title "Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases" @default.
- W4386797584 cites W1523279756 @default.
- W4386797584 cites W1841005193 @default.
- W4386797584 cites W1863795766 @default.
- W4386797584 cites W1964629749 @default.
- W4386797584 cites W1970654757 @default.
- W4386797584 cites W1974531402 @default.
- W4386797584 cites W2016410441 @default.
- W4386797584 cites W2024341039 @default.
- W4386797584 cites W2034223507 @default.
- W4386797584 cites W2077465663 @default.
- W4386797584 cites W2081712068 @default.
- W4386797584 cites W2101749257 @default.
- W4386797584 cites W2107959600 @default.
- W4386797584 cites W2114715558 @default.
- W4386797584 cites W2120503144 @default.
- W4386797584 cites W2127471603 @default.
- W4386797584 cites W2143584004 @default.
- W4386797584 cites W2147122728 @default.
- W4386797584 cites W2152505144 @default.
- W4386797584 cites W2163090183 @default.
- W4386797584 cites W2163173465 @default.
- W4386797584 cites W2165869860 @default.
- W4386797584 cites W2173737475 @default.
- W4386797584 cites W2203229763 @default.
- W4386797584 cites W2284395998 @default.
- W4386797584 cites W2304692062 @default.
- W4386797584 cites W2326035963 @default.
- W4386797584 cites W2401478799 @default.
- W4386797584 cites W2409671300 @default.
- W4386797584 cites W2473972827 @default.
- W4386797584 cites W2531490221 @default.
- W4386797584 cites W2567995016 @default.
- W4386797584 cites W2574739023 @default.
- W4386797584 cites W2590764628 @default.
- W4386797584 cites W2605719240 @default.
- W4386797584 cites W2616973202 @default.
- W4386797584 cites W2625186994 @default.
- W4386797584 cites W2744684750 @default.
- W4386797584 cites W2763042654 @default.
- W4386797584 cites W2765602133 @default.
- W4386797584 cites W2793359586 @default.
- W4386797584 cites W2793623156 @default.
- W4386797584 cites W2798809372 @default.
- W4386797584 cites W2802330837 @default.
- W4386797584 cites W2803581084 @default.
- W4386797584 cites W2807488219 @default.
- W4386797584 cites W2810059222 @default.
- W4386797584 cites W2883678168 @default.
- W4386797584 cites W2888135435 @default.
- W4386797584 cites W2896439069 @default.
- W4386797584 cites W2897873128 @default.
- W4386797584 cites W2900531230 @default.
- W4386797584 cites W2900655534 @default.
- W4386797584 cites W2908367010 @default.
- W4386797584 cites W2908873329 @default.
- W4386797584 cites W2910444500 @default.
- W4386797584 cites W2916989953 @default.
- W4386797584 cites W2922087211 @default.
- W4386797584 cites W2950451781 @default.
- W4386797584 cites W2967705142 @default.
- W4386797584 cites W2969131089 @default.
- W4386797584 cites W2979317771 @default.
- W4386797584 cites W2989928744 @default.
- W4386797584 cites W3004706073 @default.
- W4386797584 cites W3004993637 @default.
- W4386797584 cites W3005355430 @default.
- W4386797584 cites W3008546136 @default.
- W4386797584 cites W3009194131 @default.
- W4386797584 cites W3009520465 @default.
- W4386797584 cites W3009831695 @default.
- W4386797584 cites W3010291540 @default.
- W4386797584 cites W3012033772 @default.
- W4386797584 cites W3015016698 @default.
- W4386797584 cites W3015141182 @default.
- W4386797584 cites W3035764705 @default.
- W4386797584 cites W3041319315 @default.
- W4386797584 cites W3048341121 @default.
- W4386797584 cites W3081580655 @default.
- W4386797584 cites W3096644126 @default.
- W4386797584 cites W3101114845 @default.
- W4386797584 cites W3116288809 @default.
- W4386797584 cites W3128502225 @default.
- W4386797584 cites W3132793250 @default.
- W4386797584 cites W3140228111 @default.
- W4386797584 cites W3185836696 @default.
- W4386797584 cites W3195571234 @default.
- W4386797584 cites W3197363492 @default.
- W4386797584 cites W3198740632 @default.